Skip to main content

Immuron Ltd

IMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660046

No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.

Superinvestors holding IMRN, Q2 2026

See all superinvestors

No superinvestor reported holding IMRN in Q2 2026.